Shanika Samarasekera

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial

Laura H. Goldstein, Emily Robinson, John D. C. Mellers et al. · The Lancet Psychiatry · 2020 · 279 citations · Full text

Medicine, Neurology, Psychiatry +14

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Clinical outcomes of VNS therapy with AspireSR® (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre

Preci Hamilton, Imad Soryal, Prince A. Dhahri et al. · Seizure · 2018 · 106 citations

Medicine, Neurological Surgery, Neurology +14

Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies

Shanika Samarasekera, Angela Vincent, John L. Welch et al. · Journal of Neurology Neurosurgery & Psychiatry · 2006 · 53 citations · Full text

Medicine, Neurology, Neuroscience +12